Search results
Regulus Therapeutics (RGLS): An Attractive Valuation or a Potential Value Trap?
GuruFocus.com via Yahoo Finance· 8 months agoValue-focused investors are always on the hunt for stocks that are priced below their intrinsic...
7 Penny Stocks With 10x Potential This Year
InvestorPlace via Yahoo Finance· 2 years agoPenny stocks can multiply in value quickly, these picks have 10x potential this year. Regulus Therapeutics (RGLS): Represents traditional pharma...
Regulus (RGLS) Up on Top-Line Data from Kidney Disease Study
Zacks via Yahoo Finance· 2 years agoRegulus Therapeutics (RGLS) reports positive top-line data from a phase I single-dose ascending...
Regulus (RGLS) Surges on Enrollment Completion for RGLS8429
Zacks via Yahoo Finance· 1 year agoRegulus’ RGLS shares were up almost 35% on Apr 13, after it announced the completion of patient...
Regulus Shares Surge After Early-Stage RGLS8429 Data In Rare Kidney Disease
Benzinga via Yahoo Finance· 2 years agoBiopharmaceutical company Regulus Therapeutics Inc (NASDAQ: RGLS) shares jumped after topline safety...
13 Best Biotech Penny Stocks To Buy Now
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we will be taking a look at the 13 best biotech penny stocks to buy now. To skip our detailed analysis of these stocks, you can go...
Sanofi Opts To Terminate Rare Disease Program With Regulus Therapeutics
Benzinga via Yahoo Finance· 1 year agoSanofi SA (NASDAQ: SNY) elected to terminate its second amended and restated collaboration and...
Amid RNA Setbacks, Start Up Bets On Sanofi's siRNA Platform
Benzinga via Yahoo Finance· 2 years agoLow profile startup Rona Therapeutics Inc has obtained exclusive rights worldwide to Sanofi SA's...